Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 19, 2011
Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoringSander Croes, Arjen H Koop, Stephan A van Gils, et al.
Therapeutic Drug Monitoring|September 30, 2015
Evaluation of Vancomycin Prediction Methods Based on Estimated Creatinine Clearance or Trough LevelsMichiel Haeseker, Sander Croes, Cees Neef, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2010
Unpredictable effects of rifampin as an adjunctive agent in elimination of rifampin-susceptible and -resistant Staphylococcus aureus strains grown in biofilmsSander Croes, Patrick S Beisser, Cees Neef, et al.
ACS Applied Materials & Interfaces|June 1, 2011
Antimicrobial and anti-thrombogenic features combined in hydrophilic surface coatings for skin-penetrating catheters. Synergy of co-embedded silver particles and heparinSander Croes, Ellen E Stobberingh, Kris N J Stevens, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 7, 2019
Development and validation of a fast and sensitive UHPLC-DAD assay for the quantification of nitrofurantoin in plasma and urineRixt A Wijma, Karin E J Hoogtanders, Sander Croes, et al.
Plos One|November 13, 2014
Vancomycin dosing in neutropenic patientsMichiel B Haeseker, Sander Croes, Cees Neef, et al.
BMC Microbiology|October 30, 2009
Staphylococcus aureus biofilm formation at the physiologic glucose concentration depends on the S. aureus lineageSander Croes, Ruud H Deurenberg, Marie-Louise L Boumans, et al.
Therapeutic Advances in Medical Oncology|December 9, 2024
Patient perspectives on treatment-related toxicities and therapeutic drug monitoring with tyrosine kinase inhibitors for the treatment of non-small-cell lung cancerJudith Gulikers, Jeroen Bruinsma, Janna Schoenmaekers, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2020
Ultra-performance liquid chromatography for quantification of amphotericin B plasma concentrations after use of liposomal amphotericin BRuth Van Daele, Yvo de Beer, Sander Croes, et al.
Biomedical Chromatography : BMC|August 7, 2021
Development and validation of an HPLC-MS/MS method to simultaneously quantify alectinib, crizotinib, erlotinib, gefitinib and osimertinib in human plasma samples, using one assay runArd van Veelen, Robin van Geel, Roy Schoufs, et al.
Pageof 5